CONSOLIDATED STATMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional paid-in capital	Treasury Stock	Accumulated deficit
Beginning balance, common shares (in shares) at Dec. 31, 2020		105,000,000
Beginning balance at Dec. 31, 2020	$ 100,397	$ 11	$ 108,224	$ 0	$ (7,838)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,437)				(2,437)
Equity-based compensation expense	25		25
Ending balance, common shares (in shares) at Mar. 31, 2021		105,000,000
Ending balance at Mar. 31, 2021	$ 97,985	$ 11	108,249	0	(10,275)
Beginning balance, common shares (in shares) at Dec. 31, 2021	135,566,227	135,556,227
Beginning balance at Dec. 31, 2021	$ 122,368	$ 14	253,744	$ 0	(131,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(18,825)				(18,825)
Equity-based compensation expense	3,858		3,858
Repurchase of shares as a result of Forward Share Purchase Agreements (in shares)		(9,952,803)		(9,952,803)
Repurchase of shares as a result of Forward Share Purchase Agreements	$ (57,350)			$ (57,350)
Ending balance, common shares (in shares) at Mar. 31, 2022	125,613,424	125,603,424
Ending balance at Mar. 31, 2022	$ 50,051	$ 14	$ 257,602	$ (57,350)	$ (150,215)